Credit Agricole S A Myriad Genetics Inc Transaction History

Credit Agricole S A

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2018 May 14, 2018	SELL	$28.83 - $41.01 $1.29 Million - $1.83 Million	-44,726 Closed	0 $0
Q4 2017 Feb 13, 2018	SELL	$28.45 - $37.14 $2.84 Million - $3.7 Million	-99,686 Reduced 69.03%	44,726 $1.54 Million
Q3 2017 Nov 14, 2017	SELL	$24.01 - $36.2 $4.09 Million - $6.16 Million	-170,250 Reduced 54.11%	144,412 $5.23 Million
Q2 2017 Aug 14, 2017	BUY	N/A	314,662	314,662 $8.13 Million

239

92.1M

86.1K

18.9K

Ticker MYGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 80,634,800
Market Cap $541M
Description
Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...

Get notified when there are updates to the investment portfolio of Credit Agricole S A, based on Form 13F filings with the SEC.

Stay updated on Credit Agricole S A with notifications on news.